Tom H Johnston Selected Research

Tom H Johnston Research Topics

Disease

45	Parkinson Disease (Parkinson's Disease) 01/2021 - 02/2005
36	Dyskinesias (Dyskinesia) 01/2021 - 07/2004
7	Parkinsonian Disorders (Parkinsonism) 01/2019 - 11/2006
5	Psychotic Disorders (Schizoaffective Disorder) 07/2014 - 09/2006
3	Chorea (Rheumatic Chorea) 06/2011 - 06/2006
3	Dystonia (Limb Dystonia) 06/2011 - 06/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 07/2008
2	Synucleinopathies 01/2019 - 01/2016
2	Disease Progression 01/2006 - 07/2004
1	Cognitive Dysfunction 01/2021
1	Huntington Disease (Huntington's Disease) 01/2019
1	Diabetes Mellitus 03/2015
1	Alternating hemiplegia of childhood 01/2013
1	Hallucinations (Hallucination) 05/2012
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 02/2011
1	Catalepsy 09/2008
1	Atrophy 07/2008

Drug/Important Bio-Agent (IBA)

36	Levodopa (L Dopa)FDA LinkGeneric 01/2021 - 07/2004
20	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2019 - 06/2006
10	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 06/2010
3	Amantadine (Aman)FDA LinkGeneric 11/2018 - 11/2006
3	alpha-SynucleinIBA 01/2016 - 10/2010
3	5-HT1A Serotonin ReceptorIBA 10/2015 - 01/2012
3	Pharmaceutical PreparationsIBA 08/2015 - 11/2005
3	Dopamine Agents (Dopaminergic Agents)IBA 10/2013 - 09/2008
2	oxidized low density lipoproteinIBA 01/2018 - 03/2013
2	Serotonin (5 Hydroxytryptamine)IBA 10/2015 - 07/2014
2	3- ((4- (4- chlorophenyl)piperazin- 1- yl)methyl)- 1H- pyrrolo(2,3- b)pyridineIBA 02/2015 - 08/2012
2	N- methyl- 1- cyclopropyl- 1- piperonylmethylamineIBA 07/2014 - 01/2012
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 05/2012 - 05/2011
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 05/2012 - 01/2012
2	Quetiapine Fumarate (Seroquel)FDA Link 05/2012 - 11/2006
2	Clozapine (Clozaril)FDA LinkGeneric 05/2012 - 11/2006
2	Antipsychotic Agents (Antipsychotics)IBA 05/2012 - 11/2006
2	Oxidopamine (6 Hydroxydopamine)IBA 01/2011 - 04/2008
2	Haloperidol (Haldol)FDA LinkGeneric 09/2008 - 11/2006
2	Neuroprotective AgentsIBA 01/2006 - 07/2004
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2021
1	DisaccharidesIBA 01/2019
1	pridopidineIBA 01/2019
1	TrehaloseIBA 01/2019
1	Capsules (Microcapsules)IBA 11/2018
1	N-Methylaspartate (NMDA)IBA 11/2018
1	DPI-289IBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2018
1	3- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methylpyrimidin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA 10/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	PPAR gammaIBA 03/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2015
1	Pioglitazone (Actos)FDA Link 03/2015
1	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 02/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 10/2013
1	TC-8831IBA 10/2013
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 03/2013
1	entacapone (Comtan)FDA Link 03/2013
1	N- (6- (2- aminophenylamino)- 6- oxohexyl)- 4- methylbenzamideIBA 02/2013
1	Histone Deacetylase InhibitorsIBA 02/2013
1	Adenosine Triphosphatases (ATPase)IBA 01/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2013
1	Illicit Drugs (Recreational Drugs)IBA 05/2012
1	1- (2- methoxyphenyl)- 4- (4- (2- phthalimido)butyl)piperazineIBA 05/2012
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2012
1	KetanserinIBA 01/2012
1	Naltrexone (ReVia)FDA LinkGeneric 06/2011
1	mu Opioid Receptors (mu Opioid Receptor)IBA 06/2011
1	Dihydroxyphenylalanine (Dopa)IBA 06/2011
1	Dihydrotachysterol (AT 10)IBA 06/2011
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 02/2011
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 02/2011
1	Proteins (Proteins, Gene)FDA Link 10/2010
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2010
1	Famotidine (Pepcid)FDA LinkGeneric 07/2010
1	Metabotropic Glutamate 5 ReceptorIBA 06/2010
1	pyridineIBA 06/2010
1	NociceptinIBA 10/2008
1	J 113397IBA 10/2008
1	Adenosine (Adenocard)FDA LinkGeneric 09/2008
1	1-aminocyclopentane-1,3,4-tricarboxylic acidIBA 09/2008
1	Adenosine A2 Receptor AntagonistsIBA 09/2008
1	Glutamic Acid (Glutamate)FDA Link 09/2008
1	sarsasapogeninIBA 07/2008
1	Nerve Growth Factors (Neurotrophins)IBA 07/2008
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2008
1	Receptor Activity-Modifying Protein 1IBA 04/2008
1	Apomorphine FDA Link 11/2006
1	Dopamine Agonists (Dopamine Agonist)IBA 09/2006
1	imetitIBA 06/2006
1	Histamine AgonistsIBA 06/2006
1	4-(1H-imidazol-4-ylmethyl)piperidineIBA 06/2006
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 06/2006

Therapy/Procedure

12	Therapeutics 01/2021 - 11/2006